Table 167 Percent of central venous catheter placement with associated mechanical adverse events, United States, 2005a |
Population group |
Percent |
SE |
Total |
|
3.20 |
0.32 |
Age |
Under 65 |
3.28 |
0.70 |
65-74 |
3.46 |
0.58 |
75-84 |
2.43 |
0.49 |
85 and over |
4.48 |
1.10 |
Gender |
Female |
3.61 |
0.46 |
Male |
2.72 |
0.44 |
Race |
White |
3.09 |
0.35 |
Black |
3.78 |
0.96 |
Other |
* |
* |
Diabetes |
Yes |
3.29 |
0.52 |
No |
3.14 |
0.41 |
Obesity |
Yes |
2.81 |
0.72 |
No |
3.29 |
0.36 |
Cerebrovascular disease |
Yes |
2.23 |
0.55 |
No |
3.51 |
0.39 |
CHF/pulmonary edema |
Yes |
3.67 |
0.58 |
No |
2.94 |
0.39 |
COPD |
Yes |
2.90 |
0.54 |
No |
3.34 |
0.40 |
Smoking |
Yes |
4.04 |
0.93 |
No |
3.08 |
0.35 |
Corticosteroids |
Yes |
* |
* |
No |
3.32 |
0.35 |
Coronary artery disease |
Yes |
3.13 |
0.45 |
No |
3.27 |
0.46 |
Renal disease |
Yes |
3.86 |
0.55 |
No |
2.74 |
0.39 |
aData include Medicare beneficiaries discharged from January to December.
*Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.